Determination of talinolol in human plasma by high performance liquid chromatography-electrospray ionization mass spectrometry: Application to pharmacokinetic study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 853, Issue 1-2, 2007, Pages 275-280

  He, Juan ^a   Terhaag, Bernd ^b   Yang, Li Ying ^c   Zhang, Bi Kui ^a   Su, Fen Li ^a   Zhu, Yun Gui ^a   Song, Juan ^a   Tang, Jing ^a   Liu, Xiao Lei ^a   Peng, Wen Xing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Arzneimittelwerk Dresden GmbH   (Germany)

^c Tsinghua University   (China)

Author keywords

HPLC MS ESI; Pharmacokinetics; Talinolol

Indexed keywords

DRUG PRODUCTS; ELECTROSPRAY IONIZATION; ETHERS; EXTRACTION; MASS SPECTROMETRY; PLASMA (HUMAN);

CALIBRATION CURVES; ORGANIC PHASE; PROPRANOLOL; TALINOLOL;

PHARMACOKINETICS;

ACETONITRILE; AMMONIUM ACETATE; PROPRANOLOL; TALINOLOL; TERT BUTYL METHYL ETHER;

ACCURACY; ADULT; ARTICLE; CALIBRATION; CHINESE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG SCREENING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; STANDARD; TABLET; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANTIHYPERTENSIVE AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MALE; MOLECULAR STRUCTURE; PROPANOLAMINES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 34249995204     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.03.035     Document Type: Article

References (30)

1. Campeanu A. Eur. J. Heart Fail. 3 (2001) 377
2. Assmann I. Curr. Med. Res. Opin. 13 (1995) 325
3. Maurer H.H., Tenberken O., Kratzsch C., et al. J. Chromatogr. A 1058 (2004) 169
4. Campeanu A., Olinescu R., Vasile M., et al. Cardiovasc. Drugs Ther. Abstr. 263 (1999) 131
5. Campeanu A., Olinescu R., Vasile M., et al. Cardiovasc. Drugs Ther. Abstr. 68 (1999) 131
6. Love J.N., Litovitz T.L., Howell J.M., et al. Toxicol. Clin. Toxicol. 35 (1997) 353
7. Love J.N. J. Emerg. Med. 18 (2000) 341
8. Love J.N., Enlow B., Howell J.M., et al. Emerg. Med. 40 (2002) 603
9. Gramatte T., Oertel R., Terhaag B., et al. Clin. Pharmacol. Ther. 59 (1996) 541
10. Spahn-Langguth H., and Langguth P. Euro J. Pharm. Sci. 12 (2001) 361
11. Krueger M., Achenbach H., Terhaag B., et al. Int. J. Clin. Pharm. Ther. 39 (2001) 61
12. Werner S., Karen L., Georg E., et al. J. Pharmaceutic. Sci. 92 (2003) 560
13. Schwarz U.I., Gramatte T., Krappweis J., et al. Int. J. Clin. Pharm. Ther. 38 (2000) 161
14. Ulrike W., Hildegard S., Ernst L., et al. Pharmaceutic. Res. 13 (1996) 514
15. Giessmann T., May K., Modess C., et al. Clin. Pharmacol. Ther. 76 (2004) 192
16. Oertel R., Richter K., Trausch B., et al. J. Chromatogr. B 660 (1994) 353
17. Oertel R., Richter K., Gramatte T., et al. J. Chromatogr. A 797 (1998) 203
18. Zhang W.X., Chen G.L., Zhang W., et al. Clin. Chim. Acta 359 (2005) 46
19. Emmanuel B., Chantal G., and G'erard H. J. Chromatogr. B 820 (2005) 103
20. Westphal K., Weinbrenner A., Zschiesche M., et al. Clin. Pharmacol. Ther. 68 (2000) 345
21. Werner W., Annika B., Gramatte T., et al. Pharmaceut. Res. 22 (2005) 728
22. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 75 (2003) 3019
23. Macheras P., and Argyrakis P. Pharm. Res. 14 (1997) 842
24. Zhou H. J. Clin. Pharmacol. 43 (2003) 211
25. Westphal K., Weinbrenner A., Giessmann T., et al. Clin. Pharmacol. Ther. 68 (2000) 6
26. Terhaag B., Gramatte T., Richter K., et al. Int. J. Clin. Pharmacol. Ther. Toxicol. 27 (1989) 170
27. Chan L.M.S., Lowes S., and Hirst B.H. Eur. J. Pharm. Sci. 21 (2004) 25
28. Chandra P., and Brouwer K.L.R. Pharm. Res. 21 (2004) 719
29. Jonker J.W., and Schinkel A.H. J. Pharmacol. Exp. Ther. 308 (2004) 2
30. Koepsel H. Trends Pharmacol. Sci. 25 (2004) 375